Repros Therapeutics Reports Fourth Quarter And Year End 2016 Financial Results Post author:Sam Post published:March 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017 Journalist Sues FDA for Documents Related to Sarepta's DMD Drug May 25, 2017 Anpac Bio-Medical Science CEO Keynote Speaker At * Monday, July 11, 2016 July 8, 2016
Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017